First author, year, country | Study design | N | N with hearing loss (HL) | Age (mean) | Mode of balance assessment | STROBE quality | Vision assessment | Findings |
Alarcon, 2013, Spain26 | M cohort | 26 ScCMV | 17 (severity not specified) CI use not reported | 8.7 years | Movement ABC-2 | Moderate | Not specified |
|
De Kegel, 2015, Belgium28 | Case–control | 26 ScCMV 38 AcCMV 107 cCMV negative controls | 19 (ScCMV 83.2 dB; AcCMV 94.0 dB)* 9 using CI | 24 months | Ghent Developmental Balance Test | Moderate–low | Not reported |
|
Harris, 1984, USA25 | P cohort | 50 cCMV | 5 (1 MI, 4 total) CI use not reported | 3 months | Traction response test | Moderate–low | Ophthalmological examination |
|
Korndewal, 2017, Netherlands27 | R cohort | 26 ScCMV 107 AcCMV | 2 ScCMV 3 AcCMV (2 ears MO, 1 ear SE, 4 ears PR) CI use not reported | 5 years, 6 months | Movement ABC Physical therapist report | Moderate | Ophthalmological examination. Optometrist examination. |
|
Study design: R=retrospective, P=prospective, M=mixed (retrospective and prospective)
Hearing loss=severity reported where available.
Mode of balance assessment please see appendix A for glossary of vestibular and balance investigations.
Findings: (n)=number of cCMV cases out of N; where number of children tested is different to N, (n out of….) is reported.
*Where only mean decibel (dB) hearing threshold was reported, this can be interpreted as: <20 dB=normal; 21–40 dB=mild; 41–70 dB=moderate; 71–90 dB=severe; 91–119 dB=profound (Bernard, 2015).
ABC, assessment battery for children; AcCMV, asymptomatic cCMV; CI, cochlear implant; M, mixed (retrospective and prospective); MI, mild; MO, moderate; N, number of cCMV cases; P, prospective; PR, profound; r, Retrospective; ScCMV, symptomatic CMV; SE, severe; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology.